Showing results 7 to 12 of 12
PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease Park, Hyejin; Kam, Tae-In; Peng, Hanjing; Chou, Shih-Ching; Mehrabani-Tabari, Amir A.; Song, Jae-Jin; Yin, Xiling; et al, CELL, v.185, no.11, pp.1943 - 1959, 2022-05 |
PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease Jo, Areum; Lee, Yunjong; Kam, Tae-In; Kang, Sung-Ung; Neifert, Stewart; Karuppagounder, Senthilkumar S.; Khang, Rin; et al, SCIENCE TRANSLATIONAL MEDICINE, v.13, no.604, 2021-07 |
Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases Park, Hyejin; Kam, Tae-In; Dawson, Ted M.; Dawson, Valina L., CELL DEATH REGULATION IN HEALTH AND DISEASE - PT C, v.353, pp.1 - 29, 2020 |
Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson's disease Kam, Tae-In; Mao, Xiaobo; Park, Hyejin; Chou, Shih-Ching; Karuppagounder, Senthilkumar S.; Umanah, George Essien; Yun, Seung Pil; et al, SCIENCE, v.362, no.6414, 2018-11 |
Recent advances in preventing neurodegenerative diseases Chou, Shih-Ching; Aggarwal, Akanksha; Dawson, Valina L.; Dawson, Ted M.; Kam, Tae-In, Faculty Reviews, v.10, 2021 |
TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease Seo, Bo Am; Kim, Donghoon; Hwang, Heehong; Kim, Min Seong; Ma, Shi-Xun; Kwon, Seung-Hwan; Kweon, Sin Ho; et al, NEURON, v.109, no.23, pp.3758 - 3774, 2021-12 |
Discover